APOB and Insulin resistance: The results of this randomised clinical trial demonstrated that in forty-two diabetic participants, BVFE produced significant decrease in TG, TC, LDL-c, apoB, insulin resistance, glucose, insulin and significant increase in TAC compared to the placebo group at the end of study.